Tentative Cut Point of High-Sensitivity C-Reactive Protein for a Component of Metabolic Syndrome in Japanese

被引:21
作者
Oda, Eiji [1 ]
Kawai, Ryu [1 ]
机构
[1] Tachikawa Med Ctr, Med Check Up Ctr, Nagaoka, Niigata 9400053, Japan
关键词
High-sensitivity C-reactive protein; Inflammation; Metabolic syndrome; Obesity; ASSOCIATION; POPULATION; TIME; INFLAMMATION; STATEMENT; CRITERIA; MARKERS; GENDER; MEN;
D O I
10.1253/circj.CJ-08-0848
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: High-sensitivity C-reactive protein (hs-CRP) is an independent risk factor of diabetes and cardiovascular disease, and is proposed as a component of metabolic syndrome (MetS). An optimal cut point of hs-CRP as a component of MetS was previously reported as 0.65 mg/L based on data from a small-sized study. Methods and Results: Medical check-up data of 1,062 men and 647 women whose plasma levels of hs-CRP were < 10mg/L were examined using a receiver-operating characteristic (ROC) curve for diagnosing MetS, which was defined by revised NCEP criteria for Japanese. An optimal cut point was defined as the point on a ROC curve nearest to the point where both sensitivity and specificity were 1. The area under the ROC curve of hs-CRP was 0.74 (95% confidence interval (CI) 0.70-0.79) in men and 0.73 (95%CI 0.66-0.79) in women. The optimal cut point of hs-CRP and its sensitivity-specificity were, respectively, 0.45mg/L and 0.67-0.72 in men and 0.25 mg/L and 0.71-0.62 in women. Conclusions: Among Japanese patients, a tentative cut point of hs-CRP as a component of MetS may be 0.45 mg/L in men and 0.25 mg/L in women. However, standardization of the measurement of hs-CRP is required. (Circ J 2009; 73: 755-759)
引用
收藏
页码:755 / 759
页数:5
相关论文
共 31 条
[1]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]  
[Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794
[3]   Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation [J].
Dandona, P ;
Aljada, A ;
Chaudhuri, A ;
Mohanty, P ;
Garg, R .
CIRCULATION, 2005, 111 (11) :1448-1454
[4]   Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population - The Hisayama Study [J].
Doi, Y ;
Kiyohara, Y ;
Kubo, M ;
Ninomiya, T ;
Wakugawa, Y ;
Yonemoto, K ;
Iwase, M ;
Iida, M .
DIABETES CARE, 2005, 28 (10) :2497-2500
[5]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[6]   Does the metabolic syndrome exist? [J].
Grundy, Scott M. .
DIABETES CARE, 2006, 29 (07) :1689-1692
[7]   Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].
Grundy, SM ;
Cleeman, JI ;
Daniels, SR ;
Donato, KA ;
Eckel, RH ;
Franklin, BA ;
Gordon, DJ ;
Krauss, RM ;
Savage, PJ ;
Smith, SC ;
Spertus, JA ;
Costa, F .
CIRCULATION, 2005, 112 (17) :2735-2752
[8]   Coronary spasm is associated with chronic low-grade inflammation [J].
Itoh, Teruhiko ;
Mizuno, Yuji ;
Harada, Eisaku ;
Yoshimura, Michihiro ;
Ogawa, Hisao ;
Yasue, Hirofumi .
CIRCULATION JOURNAL, 2007, 71 (07) :1074-1078
[9]   The metabolic syndrome: Time for a critical appraisal - Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes [J].
Kahn, R ;
Buse, J ;
Ferrannini, E ;
Stern, M .
DIABETES CARE, 2005, 28 (09) :2289-2304
[10]   The metabolic syndrome (emperor) wears no clothes [J].
Kahn, Richard .
DIABETES CARE, 2006, 29 (07) :1693-1696